| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 19,592 | 33,545 | | Cost of Revenue | 5,378 | 2,568 | | | Gross Profit | 14,215 | 30,978 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 824 | 265 | | Non Recurring |
-
|
-
| | Others |
-
|
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 13,391 | 30,713 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (187,442) |
-
| | Earnings Before Interest And Taxes | 13,391 | 5,063 | | Interest Expense | 1,319 | 341 | | Income Before Tax | 12,072 | 4,722 | | Income Tax Expense |
-
|
-
| | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | (175,369) | 30,371 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (175,369) | 30,371 | | Preferred Stock And Other Adjustments | (2,738) | (1,020) | | | Net Income Applicable To Common Shares | ($178,107) | $29,352 |
|
0.20% Nasdaq 
Income Statement
